• IEM 1460: AMPA Receptor Blocker for Neuroprotection Assays

  2026-07-08

  IEM 1460 empowers neuroscience researchers with selective AMPA receptor blockade, enabling precise dissection of excitotoxicity and neuroprotection mechanisms. Its workflow-friendly solubility and high purity support robust, reproducible protocols for both in vitro and in vivo studies.

• Fluorescein TSA Fluorescence System Kit: Optimizing Signal D

  2026-07-07

  Empower your IHC, ICC, and ISH workflows with the Fluorescein TSA Fluorescence System Kit for ultra-sensitive detection of low-abundance targets. Discover how its robust tyramide signal amplification outperforms conventional fluorescence detection, with practical protocol enhancements and troubleshooting strategies.

• D-Luciferin Sodium Salt: Precision Firefly Luciferase Substr

  2026-07-07

  D-Luciferin sodium salt stands as the gold-standard firefly luciferase substrate, enabling sensitive, ATP-dependent bioluminescence for cell viability, metabolism, and advanced immunotherapy research. This article translates cutting-edge reference findings into actionable protocols, workflow enhancements, and troubleshooting strategies for maximizing assay reproducibility and imaging fidelity.

• Ionomycin Free Acid (SKU B6947): Reliable Calcium Ionophore

  2026-07-06

  This article presents scenario-driven guidance for life science researchers using Ionomycin free acid (SKU B6947) as a selective calcium ionophore. We address common experimental and data interpretation challenges, referencing recent mechanistic studies and benchmarking APExBIO's product for reliability and workflow compatibility.

• Balsalazide Disodium: Applied Workflows in IBD and Imaging

  2026-07-06

  Balsalazide disodium dihydrate unlocks advanced inflammation research through targeted colonic delivery and radiolabeling compatibility. This guide translates recent breakthroughs and workflow refinements into actionable protocols, highlighting troubleshooting insights for reproducible results in ulcerative colitis modeling and beyond.

• Lactate-GPR81-FARP1 Axis Enables Insulin-Independent Glucose

  2026-07-05

  The referenced study demonstrates that L-lactate, via activation of the GPR81/FARP1 signaling axis, enhances glucose uptake in skeletal muscle independently of insulin. This discovery elucidates a metabolite-driven mechanism for glycemic control and suggests translational opportunities for targeting the GPCR signaling pathway in metabolic diseases.

• Anlotinib Hydrochloride in IADSRCT: Case Evidence and Implic

  2026-07-04

  This case report is the first to document the efficacy of anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, in treating a patient with metastatic intra-abdominal desmoplastic small round cell tumor (IADSRCT). The findings highlight anlotinib's potential as a novel therapeutic option for this rare and aggressive cancer, with manageable toxicity and favorable clinical response.

• Nanoscale MOF-Encapsulated mRNA: New Horizons in Gene Delive

  2026-07-03

  This study pioneers the encapsulation and delivery of messenger RNA (mRNA) using zeolitic imidazole framework-8 (ZIF-8) metal-organic frameworks, overcoming prior instability challenges with a polymer-assisted core-shell strategy. The findings demonstrate robust in vitro and in vivo mRNA expression, sustained stability at room temperature, and performance comparable to lipid-based systems—broadening the toolkit for non-viral gene therapy and mRNA storage.

• XAV-939: Tankyrase Inhibitor Modulating Wnt/β-Catenin Pathwa

  2026-07-03

  XAV-939 (NVP-XAV939) is a potent, cell-permeable tankyrase 1 and 2 inhibitor that suppresses Wnt/β-catenin signaling by stabilizing axin and promoting β-catenin degradation. This small molecule is widely used in cancer, fibrosis, and osteogenic differentiation studies due to its nanomolar enzyme inhibition and well-characterized mechanism. Specific protocols and application boundaries are now defined, supporting reproducibility in disease modeling and regenerative research.

• Aminopeptidase Inhibition Modulates Brain Angiotensin Activi

  2026-07-02

  This study demonstrates that aminopeptidase inhibitors such as bestatin and amastatin distinctly modulate angiotensin-evoked neuronal responses in the rat brain. The work provides mechanistic evidence that angiotensin II requires conversion to angiotensin III for neuronal activation, advancing our understanding of neuropeptidergic regulation relevant to cardiovascular and fluid balance research.

• GPR107 Deficiency Exacerbates Diabetic Nephropathy via AT1R/

  2026-07-02

  Xu et al. (2025) reveal that GPR107 plays a pivotal role in maintaining glomerular basement membrane (GBM) integrity by regulating collagen IV homeostasis in podocytes. Their findings clarify how GPR107 deficiency amplifies diabetic nephropathy through impaired AT1R endocytosis and dysregulated calcium signaling, highlighting GPR107 as a potential therapeutic target.

• Anagliptin (SK-0403): Advanced DPP-4 and Vascular Research W

  2026-07-01

  Anagliptin (SK-0403) enables precise exploration of DPP-4 inhibition and novel vasorelaxant mechanisms via Kv channel and SERCA pump modulation. Discover robust experimental workflows and troubleshooting tips tailored for metabolic and vascular research, with insights directly translatable from recent benchmark studies.

• Murine RNase Inhibitor: Precision RNA Protection in RT-PCR

  2026-07-01

  APExBIO’s Murine RNase Inhibitor delivers oxidation-resistant, selective protection against RNase A-type contamination, making it indispensable for sensitive RNA workflows such as real-time RT-PCR, cDNA synthesis, and advanced RNA mapping. Its robust performance under low DTT conditions sets a new standard for RNA degradation prevention in complex molecular biology assays.

• Thiazovivin: Technical Guidance for ROCK Inhibition Workflow

  2026-06-30

  Thiazovivin is a ROCK inhibitor used to enhance the efficiency of fibroblast reprogramming and improve human embryonic stem cell survival after dissociation. It is most suitable for stem cell research workflows requiring reliable cell viability and reprogramming outcomes. Thiazovivin is not recommended for diagnostic or therapeutic use.

• Instant Clot-Forming NO-Releasing Dressings with Tranexamic

  2026-06-30

  This study introduces a bi-layer wound dressing integrating tranexamic acid, nitric oxide donor, and propolis, achieving rapid hemostasis and robust antibacterial activity for trauma injuries. The work demonstrates how combining antifibrinolytic and antimicrobial mechanisms can address two leading causes of trauma mortality: uncontrolled bleeding and infection.

451 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page